Invention Grant
- Patent Title: Bicyclic compounds as ATX inhibitors
-
Application No.: US16569459Application Date: 2019-09-12
-
Publication No.: US10882857B2Publication Date: 2021-01-05
- Inventor: Jérôme Hert , Daniel Hunziker , Patrizio Mattei , Markus Rudolph , Petra Schmitz , Patrick Di Giorgio
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agent Katherine J. Mackenzie
- Priority: EP17161254 20170316
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D405/14 ; A61K9/20 ; A61K9/48 ; C07D498/04 ; C07D401/14 ; C07D495/04 ; C07D513/04 ; C07D519/00
Abstract:
The invention provides novel compounds having the general formula (I) wherein R1, R2, Y, W, A, X, m and n are as defined herein, compositions including the compounds and methods of using the compounds.
Public/Granted literature
- US20200002336A1 BICYCLIC COMPOUNDS AS ATX INHIBITORS Public/Granted day:2020-01-02
Information query
